Sanuwave On Track To Submit dermaPACE PMA By June 30
This article was originally published in The Gray Sheet
Executive Summary
Sanuwave Health says it is on track to wrap up a PMA submission by the end of June for its dermaPACE wound care device, which treats chronic diabetic foot ulcers with high-energy acoustic pressure waves.